Teriparatide Replacement Therapy for Hypoparathyroidism During Treatment With Lenvatinib for Advanced Thyroid Cancer: A Case Report
Thyroid cancer metastasizes in 4% of cases. Approximately two-thirds of these patients are refractory to radioactive iodine-131 (RAI) therapy and have a poor 10-year survival prognosis. Treatment with tyrosine kinase inhibitors (TKIs) may be administered in selected RAI-refractory patients. However,...
Main Authors: | Tommaso Porcelli, Francesca Sessa, Angela Caputo, Christian Catalini, Domenico Salvatore |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fendo.2018.00244/full |
Similar Items
-
Increased vertebral morphometric fracture in patients with postsurgical hypoparathyroidism despite normal bone mineral density
by: Mendonça Maira L, et al.
Published: (2013-01-01) -
A registry for patients with chronic hypoparathyroidism in Russian adults
by: Sofya Gronskaia, et al.
Published: (2020-07-01) -
Hypoparathyroidism
by: N S Kuznetsov, et al.
Published: (2012-09-01) -
Recombinant human parathyroid hormone in the therapy of hypoparathyroidism
by: A K Eremkina, et al.
Published: (2017-10-01) -
Chronic hypoparathyroidism in adults: clinical features, diagnosis, management and treatment
by: Natalia G. Mokrysheva, et al.
Published: (2019-03-01)